PVRIG
Transmembrane protein PVRIG
Also known as: C7orf15, CD112R, MGC2463, PVRIG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6DKI7
- Gene
- PVRIG
- Ensembl
- ENSG00000213413
- Chromosome
- 7
- Canonical length
- 326 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Enables phosphatase binding activity and signaling receptor activity. Involved in negative regulation of T cell receptor signaling pathway. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
326 residues, UniProt reviewed canonical sequence.
>Q6DKI7|PVRIG
1 MRTEAQVPAL QPPEPGLEGA MGHRTLVLPW VLLTLCVTAG TPEVWVQVRM EATELSSFTI
61 RCGFLGSGSI SLVTVSWGGP NGAGGTTLAV LHPERGIRQW APARQARWET QSSISLILEG
121 SGASSPCANT TFCCKFASFP EGSWEACGSL PPSSDPGLSA PPTPAPILRA DLAGILGVSG
181 VLLFGCVYLL HLLRRHKHRP APRLQPSRTS PQAPRARAWA PSQASQAALH VPYATINTSC
241 RPATLDTAHP HGGPSWWASL PTHAAHRPQG PAAWASTPIP ARGSFVSVEN GLYAQAGERP
301 PHTGPGLTLF PDPRGPRAME GPLGVRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PVRIG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- thymus: 45 nTPM
- spleen: 23 nTPM
- lymph node: 21 nTPM
- small intestine: 10 nTPM
- appendix: 6.2 nTPM
- tonsil: 5 nTPM
Single-cell type
- nk-cells: 1.4 nCPM
- t-cells: 1.2 nCPM
- foveolar cells: 0.6 nCPM
- b-cells: 0.5 nCPM
- cardiomyocytes: 0.1 nCPM
- adipocytes: 0 nCPM
Immune cell
- MAIT T-cell: 353 nTPM
- NK-cell: 335 nTPM
- gdT-cell: 297 nTPM
- memory CD8 T-cell: 294 nTPM
- naive CD4 T-cell: 214 nTPM
- naive CD8 T-cell: 212 nTPM
Brain region
- white matter: 33 nTPM
- medulla oblongata: 28 nTPM
- cerebellum: 27 nTPM
- basal ganglia: 25 nTPM
- cerebral cortex: 25 nTPM
- thalamus: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.04
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein PVRIG
- Transmembrane protein PVRIG, immunoglobulin-like domain
- Transmembrane protein PVRIG, immunoglobulin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PVRIG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PVRIG as an antibody target. Whether an autoantibody or antibody against PVRIG could matter depends on whether native PVRIG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PVRIG is annotated at the cell surface, where native PVRIG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PVRIG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...